Medicare Enrolled
Dr. Donald Andersen, M.D.
Urology Physician · West Chester, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Andersen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Andersen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Andersen
Dr. Donald Andersen is an urology physician in West Chester, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Andersen performed 12,968 Medicare services across 4,643 unique beneficiaries.
Between the years covered by Open Payments, Dr. Andersen received a total of $7,623 from 61 pharmaceutical and/or device companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Andersen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in PA
$7,623 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,968
Medicare services
Top 1% in PA for urology physician
4,643
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~648 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 6,900 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,463 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,040 | $97 | $294 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
660 | $9 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
616 | $67 | $197 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
509 | $50 | $137 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 182 | $134 | $824 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
143 | $75 | $260 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
137 | $66 | $405 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
114 | $4 | $18 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
104 | $124 | $378 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
97 | $105 | $629 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
90 | $11 | $179 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
89 | $0 | $15 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
83 | $41 | $101 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
82 | $3 | $22 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
79 | $26 | $418 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
77 | $44 | $129 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
67 | $3 | $9 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
65 | $69 | $239 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
53 | $27 | $103 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
41 | $74 | $260 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
40 | $65 | $280 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
32 | $51 | $177 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $12 | $71 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
28 | $345 | $1,290 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
26 | $28 | $158 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
21 | $133 | $1,589 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
21 | $323 | $424 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
18 | $8 | $12 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
18 | $126 | $612 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
11 | $583 | $5,548 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
11 | $2,509 | $7,605 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
11 | $59 | $509 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
11 | $20 | $240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
8.2% medium
91.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,623
Total received (2018-2024)
Avg $1,089/year across 7 years
Top 19% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
326
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,510 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$113 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,691
2023
$1,449
2022
$549
2021
$308
2020
$478
2019
$1,355
2018
$1,794
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$217
Dendreon Pharmaceuticals LLC
$216
Bayer Healthcare Pharmaceuticals Inc.
$207
Janssen Biotech, Inc.
$151
Tolmar, Inc.
$126
ABBVIE INC.
$108
PFIZER INC.
$89
Sumitomo Pharma America, Inc.
$80
Astellas Pharma US Inc
$75
Antares Pharma, Inc.
$73
Laborie Medical Technologies Corp.
$57
Myriad Genetic Laboratories, Inc.
$55
Boston Scientific Corporation
$55
Teleflex LLC
$55
UROGEN PHARMA, INC.
$53
Novartis Pharmaceuticals Corporation
$29
Mission Pharmacal Company
$17
Telix Pharmaceuticals
$16
Ferring Pharmaceuticals Inc.
$15
Top 3 companies account for 37.8% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$961
Astellas Pharma US Inc
$854
Janssen Biotech, Inc.
$536
Bayer HealthCare Pharmaceuticals Inc.
$526
PFIZER INC.
$442
PROCEPT BioRobotics Corporation
$404
Ferring Pharmaceuticals Inc.
$308
Myriad Genetic Laboratories, Inc.
$284
Bayer Healthcare Pharmaceuticals Inc.
$237
Sumitomo Pharma America, Inc.
$196
Antares Pharma, Inc.
$184
Tolmar, Inc.
$175
Boston Scientific Corporation
$158
Avadel Specialty Pharmaceuticals, LLC
$158
Axonics, Inc.
$139
Agiliti Surgical, Inc.
$135
ABBVIE INC.
$128
Teleflex LLC
$121
MEDIVATION FIELD SOLUTIONS LLC
$116
Janssen Products, LP
$99
Amgen Inc.
$86
Medtronic, Inc.
$84
AstraZeneca Pharmaceuticals LP
$79
Mission Pharmacal Company
$78
Merck Sharp & Dohme LLC
$72
Blue Earth Diagnostics Limited
$64
TOLMAR Pharmaceuticals, Inc.
$63
AbbVie, Inc.
$59
Laborie Medical Technologies Corp.
$57
Novartis Pharmaceuticals Corporation
$54
UROGEN PHARMA, INC.
$53
Endo Pharmaceuticals Inc.
$44
Telix Pharmaceuticals
$43
Merck Sharp & Dohme Corporation
$39
180 Medical, Inc.
$34
Davol Inc.
$33
Myovant Sciences Inc.
$32
Verity Pharmaceuticals Inc.
$30
Supernus Pharmaceuticals, Inc.
$28
C. R. Bard, Inc. & Subsidiaries
$26
Progenics Pharmaceuticals, Inc.
$25
Alexion Pharmaceuticals, Inc.
$24
BOSTON SCIENTIFIC CORPORATION
$23
UroGen Pharma, Inc.
$23
Aytu BioScience, Inc
$23
GENZYME CORPORATION
$22
Sun Pharmaceutical Industries Inc.
$22
NeoTract Inc.
$22
UROVANT SCIENCES INC
$21
Acerus Pharmaceuticals Corporation
$20
COLOPLAST CORP
$20
Teleflex Medical Incorporated
$20
Clarus Therapeutics Inc.
$20
ACCORD HEALTHCARE, INC.
$20
Augmenix, Inc.
$19
Clovis Oncology, Inc.
$19
Kowa Pharmaceuticals America, Inc.
$15
AMAG Pharmaceuticals, Inc.
$14
Baxter Healthcare
$12
Coloplast Corp
$12
Foundation Medicine, Inc.
$11
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Access Solutions: Weck brand · Androgel · Axonics · Axumin · BOTOX · BRACANALYSIS CDX · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL ONCOLOGY · GENTLECATH · GREENLIGHT · ILLUCCIX · INTERSTIM · INTRAROSA · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Progel · Prolaris · Prolia · Rezum Generator · Rubraca · SEGLENTIS · SpaceOAR · SpeediCath · TISSEEL · TLANDO · Trelstar · URIBEL TABS · UROLIFT · Ultomiris · Uribel · UroLift · UroLift System · Urocit-K · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
210
Per 100K population
38.8
County median income
$123,041
Nearest hospital
CHESTER COUNTY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Andersen is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 19% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Andersen experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Andersen performed 6,900 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Andersen receive payments from pharmaceutical companies?
Yes. Dr. Andersen received a total of $7,623 from 61 companies across 326 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Andersen's costs compare to other urology physicians in West Chester?
Dr. Andersen's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Andersen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in West Chester
Browse urology physicians in West Chester ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology